208 related articles for article (PubMed ID: 21397671)
1. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery.
Wu H; Liu Z; Peng J; Li L; Li N; Li J; Pan H
Int J Pharm; 2011 May; 410(1-2):31-40. PubMed ID: 21397671
[TBL] [Abstract][Full Text] [Related]
2. Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels.
Bhowmik M; Bain MK; Ghosh LK; Chattopadhyay D
Pharm Dev Technol; 2011 Aug; 16(4):385-91. PubMed ID: 20429816
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin.
Wu C; Qi H; Chen W; Huang C; Su C; Li W; Hou S
Yakugaku Zasshi; 2007 Jan; 127(1):183-91. PubMed ID: 17202799
[TBL] [Abstract][Full Text] [Related]
4. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies.
Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO
Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418
[TBL] [Abstract][Full Text] [Related]
5. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin.
Liu Z; Li J; Nie S; Liu H; Ding P; Pan W
Int J Pharm; 2006 Jun; 315(1-2):12-7. PubMed ID: 16616442
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo consideration of novel environmentally responsive ophthalmic drug delivery system.
Deshmukh PK; Gattani SG
Pharm Dev Technol; 2013; 18(4):950-6. PubMed ID: 22200332
[TBL] [Abstract][Full Text] [Related]
7. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
8. Formulation development, in vitro and in vivo evaluation of microemulsion-based gel loaded with ketoprofen.
Nikumbh KV; Sevankar SG; Patil MP
Drug Deliv; 2015; 22(4):509-15. PubMed ID: 24266589
[TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization.
Khan N; Aqil M; Imam SS; Ali A
Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411
[TBL] [Abstract][Full Text] [Related]
10. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin.
Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C
Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725
[TBL] [Abstract][Full Text] [Related]
11. In situ gelling of alginate/pluronic solutions for ophthalmic delivery of pilocarpine.
Lin HR; Sung KC; Vong WJ
Biomacromolecules; 2004; 5(6):2358-65. PubMed ID: 15530052
[TBL] [Abstract][Full Text] [Related]
12. Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results.
Gan L; Gan Y; Zhu C; Zhang X; Zhu J
Int J Pharm; 2009 Jan; 365(1-2):143-9. PubMed ID: 18773948
[TBL] [Abstract][Full Text] [Related]
13. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.
Srividya B; Cardoza RM; Amin PD
J Control Release; 2001 Jun; 73(2-3):205-11. PubMed ID: 11516498
[TBL] [Abstract][Full Text] [Related]
14. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
Gupta S; Samanta MK
Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
[TBL] [Abstract][Full Text] [Related]
16. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
Al-Kassas RS; El-Khatib MM
Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
[TBL] [Abstract][Full Text] [Related]
17. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
[TBL] [Abstract][Full Text] [Related]
18. Design and in vitro evaluation of novel sustained- release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers.
Hamza Yel-S; Aburahma MH
Pharm Dev Technol; 2010; 15(2):139-53. PubMed ID: 19895367
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
Baboota S; Shakeel F; Kohli K
Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
[TBL] [Abstract][Full Text] [Related]
20. Effects of Labrasol on the corneal drug delivery of baicalin.
Liu Z; Zhang X; Li J; Liu R; Shu L; Jin J
Drug Deliv; 2009 Oct; 16(7):399-404. PubMed ID: 19630479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
